Biogen Idec (NQ: BIIB )
192.37
+1.85
(+0.97%)
Streaming Delayed Price
Updated: 12:58 PM EDT, Apr 19, 2024
Add to My Watchlist
All News about Biogen Idec
Via Benzinga
Analyst Ratings for Biogen
October 11, 2023
Via Benzinga
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
October 07, 2023
Via Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Via Benzinga
FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing ACTEMRA®
September 29, 2023
From Biogen Inc.
Via GlobeNewswire
(BIIB) - Analyzing Biogen's Short Interest
September 20, 2023
Via Benzinga
$100 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
September 15, 2023
Via Benzinga
$1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
September 04, 2023
Via Benzinga
(BIIB) - Analyzing Biogen's Short Interest
September 01, 2023
Via Benzinga
Biogen Completes Acquisition of Reata Pharmaceuticals
September 26, 2023
From Biogen Inc.
Via GlobeNewswire
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
California Attorney General Cracks Down On Deceptive Abortion Pill Reversal Claims
September 22, 2023
Via Benzinga
Biogen Appoints Jane Grogan as Head of Research
September 06, 2023
From Biogen Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.